[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @GolfNut48846224 Golf 🔩 Golf 🔩 posts on X about $uthr, $lqda, $prtc, $bmy the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1249712127646093313/interactions)  - X Week XX -XX% - X Month XXXXX -XXXX% - X Months XXXXXX +60% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::1249712127646093313/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XX +26% - X Year XXX +43% ### Followers: XXX [#](/creator/twitter::1249712127646093313/followers)  - X Week XXX -XXXX% - X Month XXX -XXXX% - X Months XXX +7% - X Year XXX -XX% ### CreatorRank: undefined [#](/creator/twitter::1249712127646093313/influencer_rank)  ### Social Influence [#](/creator/twitter::1249712127646093313/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [$uthr](/topic/$uthr) #22, [$lqda](/topic/$lqda) #33, [$prtc](/topic/$prtc) 25%, [$bmy](/topic/$bmy) 25%, [$5billion](/topic/$5billion) 25%, [$83b](/topic/$83b) 25%, [market cap](/topic/market-cap) 25%, [$4b](/topic/$4b) XX% **Top accounts mentioned or mentioned by** [@josh44282819](/creator/undefined) [@amheshay](/creator/undefined) [@aimhardy](/creator/undefined) [@sajyboy](/creator/undefined) [@scartissue123](/creator/undefined) **Top assets mentioned** [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) ### Top Social Posts [#](/creator/twitter::1249712127646093313/posts) --- Top posts by engagements in the last XX hours "@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY" [X Link](https://x.com/GolfNut48846224/status/1972606560410165362) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-29T10:17Z XXX followers, 1360 engagements "@AmheShay @Josh44282819 Correct. Antifibrotics like pirfenidone and nintedanib will remain standard treatments for idiopathic pulmonary fibrosis (IPF). I suspect Tyvaso will predominantly be used as an add-on therapy. Tyvaso's efficacy was highest when combined with nintedanib. $LQDA $UTHR" [X Link](https://x.com/GolfNut48846224/status/1972635720767648107) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-29T12:13Z XXX followers, 1214 engagements "@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF" [X Link](https://x.com/GolfNut48846224/status/1972948354314465434) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-30T08:55Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Golf 🔩 posts on X about $uthr, $lqda, $prtc, $bmy the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.
Social category influence stocks XX%
Social topic influence $uthr #22, $lqda #33, $prtc 25%, $bmy 25%, $5billion 25%, $83b 25%, market cap 25%, $4b XX%
Top accounts mentioned or mentioned by @josh44282819 @amheshay @aimhardy @sajyboy @scartissue123
Top assets mentioned United Therapeutics, Corp. (UTHR) Bristol-Myers Squibb Co (BMY)
Top posts by engagements in the last XX hours
"@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY"
X Link @GolfNut48846224 2025-09-29T10:17Z XXX followers, 1360 engagements
"@AmheShay @Josh44282819 Correct. Antifibrotics like pirfenidone and nintedanib will remain standard treatments for idiopathic pulmonary fibrosis (IPF). I suspect Tyvaso will predominantly be used as an add-on therapy. Tyvaso's efficacy was highest when combined with nintedanib. $LQDA $UTHR"
X Link @GolfNut48846224 2025-09-29T12:13Z XXX followers, 1214 engagements
"@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF"
X Link @GolfNut48846224 2025-09-30T08:55Z XXX followers, XXX engagements
/creator/twitter::GolfNut48846224